{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:03:06Z","timestamp":1780362186692,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.7759\/cureus.50595","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:03:43Z","timestamp":1702667023000},"source":"Crossref","is-referenced-by-count":5,"title":["Mucopolysaccharidosis Type I: The Importance of Early Diagnosis for Adequate Treatment"],"prefix":"10.7759","author":[{"given":"Rui","family":"Diogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rute","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2018.01.003","article-title":"Clinical presentation and diagnosis of mucopolysaccharidoses","volume":"125","author":"Stapleton M","year":"2018","unstructured":"Stapleton M, Arunkumar N, Kubaski F, Mason RW, Tadao O, Tomatsu S. Clinical presentation and diagnosis of mucopolysaccharidoses. Mol Genet Metab. 2018, 125:4-17. 10.1016\/j.ymgme.2018.01.003","journal-title":"Mol Genet Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe CS","year":"2021","unstructured":"Hampe CS, Wesley J, Lund TC, et al.. Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement. Biomolecules. 2021, 11:189. 10.3390\/biom11020189","journal-title":"Biomolecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore D","year":"2008","unstructured":"Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis. 2008, 3:24. 10.1186\/1750-1172-3-24","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology","volume":"9","author":"Hampe CS","year":"2020","unstructured":"Hampe CS, Eisengart JB, Lund TC, Orchard PJ, Swietlicka M, Wesley J, McIvor RS. Mucopolysaccharidosis type I: a review of the natural history and molecular pathology. Cells. 2020, 9:1838. 10.3390\/cells9081838","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer J","year":"2009","unstructured":"Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics. 2009, 123:19-29. 10.1542\/peds.2008-0416","journal-title":"Pediatrics"},{"key":"ref6","unstructured":"Projecto FIND. (2023). Accessed. September 18, 2023: https:\/\/www.projetofind.pt\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner F","year":"2005","unstructured":"Baehner F, Schmiedeskamp C, Krummenauer F, et al.. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis. 2005, 28:1011-7. 10.1007\/s10545-005-0112-z","journal-title":"J Inherit Metab Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9555-1","article-title":"Respiratory and sleep disorders in mucopolysaccharidosis","volume":"36","author":"Berger KI","year":"2013","unstructured":"Berger KI, Fagondes SC, Giugliani R, et al.. Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis. 2013, 36:201-10. 10.1007\/s10545-012-9555-1","journal-title":"J Inherit Metab Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9359-8","article-title":"Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management","volume":"34","author":"Braunlin EA","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, et al.. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011, 34:1183-97. 10.1007\/s10545-011-9359-8","journal-title":"J Inherit Metab Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker393","article-title":"Orthopaedic aspects of mucopolysaccharidoses","volume":"50 Suppl 5","author":"White KK","year":"2011","unstructured":"White KK. Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford). 2011, 50 Suppl 5:v26-33. 10.1093\/rheumatology\/ker393","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2016.06.002","article-title":"Pathogenesis and treatment of spine disease in the mucopolysaccharidoses","volume":"118","author":"Peck SH","year":"2016","unstructured":"Peck SH, Casal ML, Malhotra NR, Ficicioglu C, Smith LJ. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses. Mol Genet Metab. 2016, 118:232-43. 10.1016\/j.ymgme.2016.06.002","journal-title":"Mol Genet Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-018-4139-3","article-title":"Mucopolysaccharidoses: overview of neuroimaging manifestations","volume":"48","author":"Nicolas-Jilwan M","year":"2018","unstructured":"Nicolas-Jilwan M, AlSayed M. Mucopolysaccharidoses: overview of neuroimaging manifestations. Pediatr Radiol. 2018, 48:1503-20. 10.1007\/s00247-018-4139-3","journal-title":"Pediatr Radiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0817-3","article-title":"Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome","volume":"13","author":"Shapiro EG","year":"2018","unstructured":"Shapiro EG, Whitley CB, Eisengart JB. Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome. Orphanet J Rare Dis. 2018, 13:76. 10.1186\/s13023-018-0817-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2005.11.007","article-title":"Mucopolysaccharidoses and the eye","volume":"51","author":"Ashworth JL","year":"2006","unstructured":"Ashworth JL, Biswas S, Wraith E, Lloyd IC. Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006, 51:1-17. 10.1016\/j.survophthal.2005.11.007","journal-title":"Surv Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091467","article-title":"Ophthalmological findings in mucopolysaccharidoses","volume":"8","author":"Tomatsu S","year":"2019","unstructured":"Tomatsu S, Pitz S, Hampel U. Ophthalmological findings in mucopolysaccharidoses. J Clin Med. 2019, 8:1467. 10.3390\/jcm8091467","journal-title":"J Clin Med"},{"key":"ref16","article-title":"Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3","volume":"47","author":"Scott HS","year":"1990","unstructured":"Scott HS, Ashton LJ, Eyre HJ, et al.. Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3. Am J Hum Genet. 1990, 47:802-7.","journal-title":"Am J Hum Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380010204","article-title":"A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype","volume":"1","author":"Scott HS","year":"1992","unstructured":"Scott HS, Litjens T, Hopwood JJ, Morris CP. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. Hum Mutat. 1992, 1:103-8. 10.1002\/humu.1380010204","journal-title":"Hum Mutat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(92)90053-u","article-title":"Structure and sequence of the human alpha-L-iduronidase gene","volume":"13","author":"Scott HS","year":"1992","unstructured":"Scott HS, Guo XH, Hopwood JJ, Morris CP. Structure and sequence of the human alpha-L-iduronidase gene. Genomics. 1992, 13:1311-3. 10.1016\/0888-7543(92)90053-u","journal-title":"Genomics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru MH","year":"2011","unstructured":"de Ru MH, Boelens JJ, Das AM, et al.. Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011, 6:55. 10.1186\/1750-1172-6-55","journal-title":"Orphanet J Rare Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijns8040061","article-title":"A roadmap for potential improvement of newborn screening for inherited metabolic diseases following recent developments and successful applications of bivariate normal limits for pre-symptomatic detection of MPS I, Pompe disease, and Krabbe disease","volume":"8","author":"Jalal K","year":"2022","unstructured":"Jalal K, Carter RL, Barczykowski A, Tomatsu S, Langan TJ. A roadmap for potential improvement of newborn screening for inherited metabolic diseases following recent developments and successful applications of bivariate normal limits for pre-symptomatic detection of MPS I, Pompe disease, and Krabbe disease. Int J Neonatal Screen. 2022, 8:61. 10.3390\/ijns8040061","journal-title":"Int J Neonatal Screen"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213043-mucopolysaccharidosis-type-i-the-importance-of-early-diagnosis-for-adequate-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:36Z","timestamp":1707509436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213043-mucopolysaccharidosis-type-i-the-importance-of-early-diagnosis-for-adequate-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.50595","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}